In 2016, CELLINK commercialized the world’s first bioink, a biomaterial innovation eight years in the making. That milestone was the first of many along the company’s four-year journey to become the world’s leading bioprinting company with systems used to optimize cell-based applications for more than 1,000 scientists across more than 55 countries.